CNR2 and Parkinson disease: In general, the effects of some phytocannabinoids on PD appear to be protective either by binding to the CB1 receptor, inhibiting dopamine beta hydroxylase activity and decreasing glutamate levels or by binding to CB2, reducing neuroinflammation.